adverse perinatal events is an important component of perinatal audit. We need to know whether the changes in perinatal care that have undoubtedly resulted in their improved survival have altered the incidence of impairments in their long term health, growth, or neurodevelopmental state. Moreover, recent improvements in diagnostic imaging techniques carried out in the neonatal period may considerably enhance our ability to predict longer term outcome.1-3 Their importance lies not only in their use to monitor the eventual outcome for individual children, but because therein could lie some explanation of the mechanisms linking clinical pathological entities to the lesions visualised. 4 In the absence of reliable validated routine health surveillance of all children, special studies are required to monitor the effects of rapidly changing perinatal practice and to evaluate specific components of care. Studies from any one centre are often too small to answer the questions being posed. The purpose of this paper is to discuss ways in which the design of following studies could be made compatible to enable multicentre collaboration, and thus provide more rapid feedback to neonatal paediatricians on current issues.
Background
In 1981, Kiely and Paneth outlined some of the theoretical problems that beset the design and reporting of follow up studies.5 In the same year, Sinclair et al expanded on the methodological requirements for a proper evaluation of neonatal intensive care.6 This included testing of the efficacy of particular treatments, their effectiveness in the field, the efficiency of these treatments in relation to other calls on resources, and the implications (economic and otherwise) of making them available to all who need them. In this paper we discuss some of the other issues and practical problems encountered in mounting follow up studies and suggest some solutions, but our main aim is to stimulate further discussion that will eventually encourage more effective use of the vast amount of resource and expertise expended in the name of 'follow up'.
How is the information derived from follow up studies used?
Most reported follow up studies based on hospital populations are descriptive or observational; that is, information is collected on the outcome of cohorts of children with particular characteristics-for example birthweight groups, infants who were ventilated, infants with seizures, and so on. This information tends to be misused in two ways. Firstly, associations between perinatal variables and outcome are observed, and there is then a tendency to ascribe-erroneously-a causal relationship between the two. Descriptive follow up studies can, however, only generate hypotheses that need to be tested in a new cohort. Causal relationships can be determined only by a randomised study design. Secondly, the information collected is compared with other similar observations made in previous years or in other centres. Differences in outcome are ascribed to differences in care, but they may merely reflect differences in the study population (either over time or between centres), or a lack of uniformity in the way outcomes have been defined or ascertained. The aim of the study should be defined at the outset and usually falls into one of the following categories: to estimate the incidence of disease, disorder, or impairment in a defined cohort followed up for a specific period; to evaluate the effectiveness or otherwise of a particular therapeutic intervention; or to test a specific aetiological hypothesis.
A descriptive follow up study of the first type can provide important information on the natural history and prognosis of a condition, and can identify the presence or absence of associations between perinatal events and outcome. The evaluation of specific treatments is best achieved by randomised clinical trials with predefined measurements of outcome made by investigators who are preferably 'blind' to the original treatment. The role of each type of study is illustrated in the following example.
A study of the natural history and prognosis of a group of infants with neonatal seizures identified a subgroup of infants born at full term whose seizures occurred in the first 48 hours of life and who had sustained an intrapartum insult.7 This gave rise to the aetiological hypothesis that changes in intrapartum management might reduce the number of infants born at full term with early seizures. It was then postulated that the rate of such seizures might provide a useful marker of the quality of intrapartum care. 8 Two case control studies were set up to investigate the relationship between various adverse outcomes of pregnancy including early neonatal seizures and the quality of care in pregnancy and labour; both showed that there was a strong association between suboptimal care and early seizures.9 10 The hypothesis was sustained in a large randomised controlled trial of intrapartum electronic fetal heart rate monitoring.11
DEFINITION OF THE STUDY COHORT
The criteria by which the study cohort is selected should be clearly defined and will be determined by whether the study is investigating prevalence, or the effects of an intervention, or testing a specific aetiological hypothesis.
In a study of the prevalence of morbidity, the population should be geographically defined. This permits evaluation of care to a total population whose characteristics can be defined, and hence the findings can be compared with other populations for which reference statistics are available, taking account of any differences in these variables. Results from tertiary referral centres are difficult to interpret, because they are confounded by the transfer of mothers and infants between units. An example of the importance of this source of bias was described by Horwood et al who showed that 28% of the reduction in mortality experienced after the opening of a new intensive care centre was accounted for by the transfer in from outside the geographical region of mothers who had been thought, incorrectly, to be at high risk of a poor outcome. 12 Enrolment in such a study can be on the basis of all births, or all live births. It is, however, important to ensure that a birth is also defined by some other variable such as-for example, all births over 500 g-because there is marked variation in the definition of live birth both internationally and within countries. 13 In a study of prevalence in a defined population, the study size is obviously constrained by the available eligible entrants. In testing a hypothesis it is important that the sample size is big enough to permit identification of enough subjects with the predefined outcome. For example, there is little point in examining 100 infants for the incidence of an outcome that occurs in only 1/1000. Furthermore, the sample needs to be large enough to detect intergroup differences that are also biologically important.
It is difficult to give general advice because each study has a different perspective; a statistician should be consulted to advise on the necessary calculations based on the reported frequency of a given dichotomous outcome, or some measure of central tendency and dispersion such as the mean and standard deviation of a continuous outcome measure such as growth or a developmental score. 15 It should be borne in mind that the standard deviation for a developmental score is likely to be greater in a 'high risk' population than in the standardisation sample for the test.
In order to study infrequent outcomes (such as retinopathy of prematurity) or a limited population (such as infants weighing less than 1000 g at birth)
within a reasonable time span, multicentre collaboration is essential to achieve sufficient numbers. For this to be successful, standard methods for identifying and reporting those outcomes are needed.
DEFINITION OF OUTCOMES
The outcomes to be measured will depend on the aim of the study, but whatever they are they must be specified and clearly defined before the start of the study. The outcome should be relevant to the child or family, or likely to improve our understanding of the aetiology or treatment of the condition being studied. The availability of funds or personnel, or both, may impose constraints on the study, making the choice of the most important and valid outcome measures even more essential.
Commonly reported outcomes are death, neurodevelopmental state, sensory impairment, morbidity, growth, behavioural attributes, and learning ability. It is important that the outcome to be measured can be defined accurately. In the case of death, for example, the definition is simple, whereas neurodevelopmental impairment or emotional problems would require careful definition before a study was undertaken.
In making a full evaluation of the effects of any treatment it is important to consider outcomes that have economic implications. Measures such as the need for hospital admission, length of stay, the need for increased primary health care contacts, and the use of ancillary services are important factors that could influence whether recommendations based on the findings of a particular study are accepted.
Measuring outcomes
The tests (tools) used in measuring outcome should have both reproducibility and validity. These terms are illustrated in the figure (JC Sinclair, personal communication).
Even with standardised 'tests' inaccuracies, imprecision, and biases can arise. There is a real chance of interobserver variation-and also intraobserver variation-and these need to be tested in a pilot study. It has been shown that further training can help to improve the level of agreement between observers.'6 The problem is accentuated when non-standardised tests, sometimes devised by the examiner, are used before being subjected to rigorous evaluation. There is a large number of tests currently in use for assessing a wide variety of functions at differing ages and we do not intend to discuss specific ones here. There is, however, a need for some consensus on the optimal ages for testing children and the most appropriate tests at each age in order to achieve comparability between studies.
Outcome measures that require intensive assessment by highly trained personnel are not feasible if the study population is large. Conversely, smaller studies on their own, or 'nested' in large trials, may provide the opportunity for in depth examination of unsuspected effects of the treatments being compared.
Other sources of outcome information In addition to data collected in the study there are several other sources which can be used to find out about the longer term health and development of children. Information on deaths in the study cohort can usually be obtained from routinely collected data held by districts on the child health register, as the death of a child is entered immediately to ensure that parents are not contacted for routine appointments.
Where appropriate, for a small cost, the National Health Service record of individuals held by the Office of Population Censuses and Surveys can be 'flagged' so that the researcher will be informed of the death or emigration of study children, or their movement from one family practitioner committee area to another.
Parents, health visitors, general practitioners, community child health doctors, hospital paediatricians, and teachers as well as research workers Disability-Assigning grades of severity to the disability arising from impairments is fraught with problems. In prevalence studies it is important that the 'cut off' point for ascertaining the condition under review is predefined for comparative purposes, as children with minimal problems may well not be universally recognised, and the reader needs to know the threshold of inclusion. The description of disability needs to be related to a particular task and the developmental age of the child and must take account of the use and usefulness of aids.2' In most currently reported studies, however, there is a lack of uniformity in describing disability in children and this is compounded by the arbitrary categorisation of disabilities into grades of 'mild', 'moderate', and 'severe', which may have different meanings in different studies. Furthermore, a physician's perception of the severity of a disability will depend on his or her clinical experience.
In a population based study in the Northern region of England a system was developed to categorise the degree of disability in a group of children with established cerebral palsy in which aspects of mobility, physical dependence, social and economic implications and resource use were summed to provide an overall measure of disability. 22 In a recent study of disabilities in children by the Social Survey Division of the Office of Population Censuses and Surveys, considerable attention was paid to all these points; it will be a useful reference source. 23 One possible way forward would be the development of a 'minimum data set ' Handicap-This is a particularly difficult outcome for comparative use, as it depends heavily on subjective factors and is a reflection of the attitudes within the family and society as a whole to people with disabilities. It is best avoided in the types of study described here.
CHOICE OF A COMPARISON GROUP
In a controlled trial the control group should be randomly chosen from those eligible for entry to the study and therefore should be comparable with the index group in every respect other than the intervention being studied.
In an observational study there is no easy answer to the choice of a comparison group.5 As previously stated, comparison of the outcome of hospital populations either over time (historical controls) or between centres may result in misleading inferences.
The choice of a comparison group depends on the question being asked. The choice must be between matched and 'unmatched' controls; if the preference is for matched controls, then subjects could be matched on antecedent factors such as maternal age, parity, birth weight, or gestational age, depending on the design of the study. In considering developmental outcomes, however, the over-riding determining factors are sex, social class,24 and preschool 25 experience, so there is a rational basis for matching on those variables. Often it is better to match for only exceptional factors and adjust for others in the analysis. Overmatching can introduce difficulties in interpretation by taking out of consideration the very factor being investigated.
In a prevalence study in, for example, a very low birthweight population where the outcome to be measured is relatively uncommon, more than one control for each index case may be necessary to provide more accurate estimates of the increased relative risk experienced by the study subjects. But the advantage to be gained by increasing the number of controls soon falls off15; statistical advice is needed on this point.
The use of siblings as a comparison may have the advantage that socioeconomic variables and experience of parenting are likely to be the same. In some families, however, there will be no siblings and any finding limited to those cases who had a sibling would not necessarily be relevant for the one child family. Birth order in itself has been shown to have a significant effect on developmental score almost equal to that of the sex of the child. 26 At an older age group, classroom controls of the same sex and social class are an attractive alternative, but this necessarily excludes children not able to attend school who may be represented to a greater extent in the index group.
If a concurrent comparison is carried out between two geographically defined populations with the same ascertainment criteria for measures of out-'come, observed differences may indeed reflect differences in care; these may, however, also be the results of known differences in the sociodemographic structure of the populations, or to some as yet unidentified confounding factor. Information should be collected on factors known to be related to the outcome being measured, so that adjustment can be. made in the analysis for any marked imbalance.
TRACING CHILDREN
Tracing children can be time consuming, and several sources may need to be tapped.27 High ascertainment rates are extremely important, because biases arise when follow up rates are low and it should be recognised that the lower the follow up rate the more inaccurate the estimate of the true rate of impairment. There is, furthermore, some evidence that children who are difficult to trace may be at a higher risk of an abnormal outcome. The extent to which this is true has recently been quantified in a study of very low birthweight children in the Northern region of England; children not seen on the first attempt had a sevenfold increased risk of impairment compared with those who were easily traced.28
If parents are aware from the time of birth or soon after that their children will form part of a study, contact can be maintained in a number of ways. In the 1946 British cohort used to study child health, birthday cards are used to keep in touch.29 Assess- 
EXCLUSIONS AFTER ASSESSMENT
It is difficult-to make a general statement about this issue. In a randomised trial, once subjects have been assigned to a treatment they should all be included in the analysis. In an observational study of the developmental outcome of for example, children whose mothers had had some late onset pregnancy condition, then the inclusion of a child with a genetically determined syndrome would be inappropriate. When language development is a principal outcome of interest, then children whose first language differs from that of the tester are at a disadvantage, and not only in the sphere of language. Decisions about how to deal with these situations should be discussed at the outset of the study.
DISTRIBUTION OF CONFOUNDING VARIABLES
The first priority is to determine the distribution in the study group, and in the population from which the study sample was derived, of characteristics that might affect outcome such as birth weight, gestational age, sex, social class, birth order, and preschool experience. Estimates of travel costs depend on local circumstances and how far removed in age the subjects are from the age at entry into the study. For example, of a birth cohort contacted first at the age of 4 years, 80% were still living within 25 miles of the district general hospital in which they were born, 12% were between 25 and 100 miles away, and 1% were more than 200 miles away25 (unpublished data).
Ethical perspective on follow up studies It could be said that a physician has a responsibility to monitor the outcome of any treatment prescribed as part of routine health care: to ensure-for example-that a child's hearing is intact after treatment for an ear infection. The responsibility is perhaps less well defined in the perinatal period where the effectiveness of treatment for the mother is not always interpreted in the light of possible effects on the child.
The follow up systems developed by most special care nurseries provide a continuing clinical service for patients and their parents and have a counselling and supportive role as well as being a means of assessing overall health and development. Carefully designed follow up studies can be incorporated within these systems, but a fine balance needs to be achieved between fulfilling the needs of individual patients and meeting the rather stringent requirements of a research study.
Ethical approval must be sought for follow up where this is not considered an integral part of continuing clinical care. This is particularly important if a 'normal' control group is enrolled. Parents' consent should be sought after an explanation of the purpose of the study and what is entailed in the follow up assessment. This can be done orally or by letter, and parents can consent either by opting in or opting out.32 General practitioners should be informed that their patient has consented to take part in a study. Results should be communicated promptly so that they are as relevant as possible to current practice; parents and general practitioners are entitled to receive the reports of assessments.
If we are concerned to monitor the effects of changing perinatal practice, then it must also be appreciated that the effect of follow up studies in themselves has never been evaluated fully. On the one hand, benefits may accrue from the early identification of-for example-sensory deficit and the implementation of treatment; on the other hand it may be that the identification of other problems of development, some of which cannot be 'cured', might cause unnecessary anxiety to parents and children. It is therefore important that studies should not be undertaken unless they are properly designed and of sufficient size to answer specific questions.33 This counsel of perfection could well limit the number of studies but would undoubtedly increase their usefulness.
